These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35760396)

  • 1. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer.
    Tran TXM; Kim S; Cha C; Park B
    Cancer Res Treat; 2024 Apr; 56(2):522-530. PubMed ID: 37905311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
    Amboree TL; Montealegre JR; Parker SL; Garg A; Damgacioglu H; Schmeler KM; Chiao EY; Hill EG; Sonawane K; Deshmukh AA; Adsul P
    JAMA Intern Med; 2024 Jun; 184(6):671-679. PubMed ID: 38683574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.
    Mondragón Márquez LI; Domínguez Bueso DL; González Ruiz LM; Liu JJ
    Cancer Causes Control; 2023 Dec; 34(12):1073-1084. PubMed ID: 37486400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
    Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
    Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
    Onega T; Garcia M; Beaber EF; Haas JS; Breslau ES; Tosteson ANA; Halm E; Chao CR; Barlow WE
    J Gen Intern Med; 2024 Jun; 39(8):1324-1331. PubMed ID: 38097863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
    Chiereghin A; Squillace L; Pizzi L; Sanna T; Bazzani C; Roti L; Mezzetti F
    Epidemiol Prev; 2024; 48(2):158-164. PubMed ID: 38770733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast and Colorectal Cancer Screening Utilization after Hurricane María and the COVID-19 Pandemic in Puerto Rico.
    Colón-López V; Contreras-Mora HM; Pérez CM; Berríos-Ortiz H; Sánchez-Díaz CT; Disdier OM; Ríos-Morales N; Suárez-Pérez EL
    Int J Environ Res Public Health; 2023 Oct; 20(19):. PubMed ID: 37835140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening.
    Knudsen AB; Trentham-Dietz A; Kim JJ; Mandelblatt JS; Meza R; Zauber AG; Castle PE; Feuer EJ
    JAMA Netw Open; 2023 Nov; 6(11):e2344698. PubMed ID: 37991759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study.
    Njor SH; Søborg B; Tranberg M; Rebolj M
    Prev Med; 2023 Feb; 167():107405. PubMed ID: 36581010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
    Quintal C; Antunes M
    Acta Med Port; 2023 Sep; 36(9):577-587. PubMed ID: 37339163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
    Su CH; Hsu PS; Lin CS
    BMC Health Serv Res; 2023 Aug; 23(1):878. PubMed ID: 37605162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to increase participation in organised screening programs: a systematic review.
    Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study.
    Wilson R; Quinn-Scoggins H; Moriarty Y; Hughes J; Goddard M; Cannings-John R; Whitelock V; Whitaker KL; Grozeva D; Townson J; Osborne K; Smits S; Robling M; Hepburn J; Moore G; Gjini A; Brain K; Waller J
    Prev Med; 2021 Dec; 153():106826. PubMed ID: 34599921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs.
    Zhang L; Mosquera I; Lucas E; Rol ML; Carvalho AL; Basu P;
    Nat Med; 2023 May; 29(5):1135-1145. PubMed ID: 37106168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.